Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells $24,640.00 in Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 2,000 shares of Nu Skin Enterprises stock in a transaction on Monday, March 25th. The shares were sold at an average price of $12.32, for a total value of $24,640.00. Following the transaction, the director now owns 27,225 shares in the company, valued at $335,412. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Nu Skin Enterprises Stock Performance

NUS opened at $13.76 on Thursday. The firm has a market cap of $679.77 million, a PE ratio of 76.42 and a beta of 1.09. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 0.58. The business has a fifty day simple moving average of $14.95 and a 200-day simple moving average of $17.71. Nu Skin Enterprises, Inc. has a fifty-two week low of $12.06 and a fifty-two week high of $41.50.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.08. The business had revenue of $488.64 million during the quarter, compared to analyst estimates of $479.35 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. As a group, equities analysts predict that Nu Skin Enterprises, Inc. will post 1.13 EPS for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio is presently 133.34%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on NUS. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. DA Davidson lowered their price target on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 5th. Four investment analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $23.67.

Institutional Investors Weigh In On Nu Skin Enterprises

Several large investors have recently modified their holdings of the stock. Lazard Asset Management LLC acquired a new stake in shares of Nu Skin Enterprises in the second quarter worth $30,000. GAMMA Investing LLC acquired a new stake in shares of Nu Skin Enterprises in the fourth quarter worth $33,000. Eagle Bay Advisors LLC boosted its position in shares of Nu Skin Enterprises by 37.1% in the second quarter. Eagle Bay Advisors LLC now owns 809 shares of the company’s stock worth $35,000 after buying an additional 219 shares during the period. Royal Bank of Canada boosted its position in shares of Nu Skin Enterprises by 118.2% in the third quarter. Royal Bank of Canada now owns 1,150 shares of the company’s stock worth $38,000 after buying an additional 623 shares during the period. Finally, CWM LLC boosted its position in shares of Nu Skin Enterprises by 5,838.9% in the third quarter. CWM LLC now owns 2,138 shares of the company’s stock worth $45,000 after buying an additional 2,102 shares during the period. 82.84% of the stock is owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.